Europe In-Vitro Diagnostics Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
Europe In-Vitro Diagnostics Market Outlook
Europe In-Vitro Diagnostics Market will reach US$ 28.88 Billion in 2028, according to Renub Research. In-vitro diagnostics (IVD) refers to medical tests and procedures performed on samples derived from the human body, such as blood, urine, tissue, or other bodily fluids, outside of the body (in vitro) to aid in the diagnosis, monitoring, and prevention of diseases or conditions. These diagnostics tests are typically performed in a laboratory or healthcare setting and provide valuable information about a patient's health status, including infections, genetic disorders, or other medical conditions. In-vitro diagnostics include molecular diagnostics, immunoassays, clinical chemistry, hematology, and microbiology. They guide clinical decision-making, treatment selection, and disease management.
Europe's In-Vitro Diagnostics Market shall experience a CAGR of 2.19% from 2022 to 2028
Several factors, including the increasing prevalence of chronic and infectious diseases such as cardiovascular disorders, diabetes, cancer, and respiratory diseases, drives Europe's in-vitro diagnostics market. For instance, based on the GLOBOCAN report, Germany recorded approximately 628,519 new cancer cases in 2020. Among females, breast and colorectal cancer were the more prevalent types, while among males, prostate and lung cancer were the more prevalent types in the country.
Europe's aging population drives demand for IVD tests and devices. Personalized medicine, technological advancements, favourable reimbursement, regulatory policies, increasing healthcare expenditure, collaborations, partnerships, and awareness for preventive healthcare contributes to market growth. The European Union launched programs in 2020 to improve the well-being of three million cancer-affected individuals by 2030, emphasizing the understanding of cancer diagnosis; this, along with the rising prevalence of chronic diseases in Europe, shall fuel robust growth in the in-vitro diagnostics market. Hence, the market value for Europe in-vitro Diagnostics Market was US$ 25.36 Billion in 2022.
The dominance of services in the Europe in-vitro diagnostics market is due to the complexity of diagnostics tests, requiring specialized expertise and advanced equipment.
Services, Instruments, and Reagents are the three product segments in the Europe in-vitro diagnostics market. Service providers offer specialised testing services like genetic testing, molecular diagnostics, and technical pathology, ensuring accurate results. They meet quality assurance and regulatory standards, providing consistent quality and compliance. Outsourcing testing services to specialized providers offer cost-effectiveness and scalability. As a result, healthcare institutions can focus on core competencies, enhancing efficiency and patient care. Service providers invest in advanced technology and research, providing access to state-of-the-art testing services. Collaborations and partnerships drive innovation, strengthening the dominance of services in the Europe in-vitro diagnostics market.
Rapid tests will grow fastest in the Europe In-vitro Diagnostics Market
ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, and Others are the test types present in the Europe in-vitro Diagnostics Market. Rapid tests provide quick results, essential for immediate diagnosis in emergencies and infectious disease outbreaks. They can be performed at the point of care, eliminating transportation, and reducing waiting times. Rapid tests are convenient, accessible, and suitable for various healthcare settings, including remote areas. They enable early detection, leading to timely interventions, improved outcomes, and cost savings. Rapid tests quickly identify pathogens in managing infectious diseases, facilitating prompt treatment and infection control. Technological advancements enhance accuracy and ease of use. In addition, regulatory support ensures quality, safety, and confidence in rapid tests.
Infectious diseases have high Growth rate in the Europe In-vitro Diagnostics Market
Infectious Diseases, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, and Other Applications find significance in the Europe in-vitro diagnostic market. In Europe, the burden of infectious diseases is significant, driving the demand for in-vitro diagnostics tests. Outbreaks and pandemics like COVID-19 further increased the need for rapid identification and monitoring. Public health initiatives prioritize disease control, with diagnostics playing a crucial role. Europe's robust healthcare infrastructure supports efficient testing and diagnosis. Advanced technologies, regulatory support, and ongoing research contribute to the region's market dominance of infectious disease diagnostics.
Immunoassays dominate the Europe in-vitro diagnostics market due to their versatility and high sensitivity
Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, and Others are the technology used in the Europe in-vitro diagnostics market. Immunoassays dominate the European in-vitro diagnostic market due to their versatility in detecting various analyses, including proteins, hormones, antibodies, drugs, and infectious agents. They find usage in healthcare settings for testing infectious diseases, oncology, cardiovascular diseases, autoimmune disorders, and drug testing. With their high sensitivity and specificity, immunoassays provide accurate and reliable clinical decision-making and disease monitoring results.
Automation advancements make immunoassays scalable and efficient, particularly for high-volume testing. The extensive development and validation of established assay platforms ensure the reliability and accuracy of immunoassay results. European regulatory bodies enforce strict guidelines, ensuring immunoassay-based diagnostics' quality, safety, and performance. The availability of reagents, antibodies, assay components, and a robust infrastructure of diagnostic laboratories and healthcare facilities support the widespread use of immunoassays in Europe.
Technological advancements, including molecular diagnostics and automation, drive the growth of laboratories in the Europe in-vitro diagnostics market
By end-users, there are four divisions in the Europe in-vitro diagnostics market: Hospitals, Laboratories, Home - Care, and Others. Healthcare providers outsource diagnostics services to specialized laboratories to focus on core competencies and meet testing demand. Strict regulatory requirements and quality assurance standards ensure reliable results and contribute to laboratory growth. Collaborations with healthcare institutions, research organizations, and industry stakeholders drive innovation and expand laboratory services. Additionally, the substantial healthcare expenditure in Europe supports laboratory growth through investments in developing diagnostic capabilities to meet the rising demand for testing services.
Italy is the largest growing region in the Europe in-vitro diagnostics market
Based on region, there are 11 segments in the Europe in-vitro diagnostics market, notably Germany, France, Italy, Spain, Netherlands, Greece, Portugal, Austria, Belgium, Poland, and the rest of Europe. Italy's robust healthcare infrastructure, high disease burden, and rapidly aging population drive the demand for in-vitro diagnostics tests, supporting market growth. Government initiatives, healthcare investments, and technological advancements further contribute to market expansion. Collaborations and partnerships foster innovation, while well-defined regulatory frameworks ensure test safety and quality, promoting confidence and growth in the Europe in-vitro diagnostics market. The rest of Europe dominates the in-vitro diagnostics market due to its robust healthcare infrastructure, technological advancements, high healthcare expenditure, research and innovation, collaboration and partnerships, regulatory support, and increased disease burden.
Key Players
Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation are the prominent companies in the Europe in-vitro diagnostics market.
- In June 2021, During the COVID-19 pandemic, the British In Vitro Diagnostics Association (BIVDA) introduced "The Digital Revolution" strategy paper to expand the accessibility of groundbreaking in-vitro diagnostics.
Renub Research report titled “Europe in-vitro diagnostics Market Forecast by Products (Services, Instruments, and Reagents), Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, and Others), Application (Infectious Diseases, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, and Others), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, and Others), End-Users (Hospitals, Laboratories, Home - Care, and Others),Region (Germany, France, Italy, Spain, Netherlands, Greece, Portugal, Austria, Belgium, Poland, and the rest of Europe), Company Analysis (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation)" provides a detailed analysis of Europe in-vitro Diagnostics Market.
Products - Market breakup from 3 Viewpoints:
1. Services
2. Instruments
3. Reagents
Test types - Market breakup from 11 Viewpoints:
1. ELISA & CLIA
2. PCR
3. Rapid Test
4. Fluorescence Immunoassays (FIA)
5. In Situ Hybridization
6. Transcription Mediated Amplification
7. Sequencing
8. Colorimetric Immunoassay
9. Radioimmunoassay (RIA)
10. Isothermal Nucleic Acid Amplification Technology
11. Others
Application - Market breakup from 8 Viewpoints:
1. Infectious Diseases
2. Diabetes
3. Cardiology
4. Oncology
5. Nephrology
6. Autoimmune Diseases
7. Drug Testing
8. Others
Technology - Market breakup from 7 Viewpoints:
1. Immunoassay
2. Clinical Chemistry
3. Molecular Diagnostics/Genetics
4. Hematology
5. Microbiology
6. Coagulation
7. Others
End-Users - Market breakup from 4 Viewpoints:
1. Hospitals
2. Laboratories
3. Home – Care
4. Others
Regions - Market breakup from 32 Viewpoints:
1. Germany
2. France
3. Italy
4. Spain
5. Netherlands
6. Greece
7. Portugal
8. Belgium
9. Sweden
10. Austria
11. Denmark
12. Finland
13. Ireland
14. Luxembourg
15. Poland
16. Romania
17. Czechia
18. Hungary
19. Bulgaria
20. Slovakia
21. Croatia
22. Lithuania
23. Latvia
24. Slovenia
25. Estonia
26. Cyprus
27. Malta
28. Switzerland
29. Norway
30. Iceland
31. United Kingdom
32. Turkey
Company has been covered from 3 Viewpoints:
• Overview
• Recent Development
• Revenue
Company Analysis:
1. Roche Diagnostics
2. Abbott Diagnostics
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
Report Details:
| Report Features | Details |
| Base Year | 2022 |
| Historical Period | 2018 - 2022 |
| Forecast Period | 2023 - 2028 |
| Market | US$ Billion |
| Segment Covered | Product, Test Types, Technology, Application, End User and Region |
| Companies Covered | Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Porter’s Five Forces
5.1 Bargaining Power of Buyer
5.2 Bargaining Power of Supplier
5.3 Threat of New Entrants
5.4 Rivalry among Existing Competitors
5.5 Threat of Substitute Products
6. SWOT Analysis
6.1 Strengths
6.2 Weaknesses
6.3 Opportunities
6.4 Threats
7. Europe In-Vitro Diagnostics (IVD) Market
8. Market Share – Europe In-Vitro Diagnostics (IVD)
8.1 By Products
8.2 By Test Types
8.3 By Application
8.4 By Technology
8.5 By End User
8.6 By countries
9. Product – Europe In-Vitro Diagnostics (IVD) Market
9.1 Services
9.2 Instruments
9.3 Reagents
10. Test Types – Europe In-Vitro Diagnostics (IVD) Market
10.1 ELISA & CLIA
10.2 PCR
10.3 Rapid Test
10.4 Fluorescence Immunoassays (FIA)
10.5 In Situ Hybridization
10.6 Transcription Mediated Amplification
10.7 Sequencing
10.8 Colorimetric Immunoassay
10.9 Radioimmunoassay (RIA)
10.10 Isothermal Nucleic Acid Amplification Technology
10.11 Others
11. Application – Europe In-Vitro Diagnostics (IVD) Market
11.1 Infectious Disease
11.2 Diabetes
11.3 Cardiology
11.4 Oncology
11.5 Nephrology
11.6 Autoimmune Diseases
11.7 Drug Testing
11.8 Other Applications
12. Technology – Europe In-Vitro Diagnostics (IVD) Market
12.1 Immunoassay
12.2 Clinical Chemistry
12.3 Molecular Diagnostics/Genetics
12.4 Hematology
12.5 Microbiology
12.6 Coagulation
12.7 Others
13. End User – Europe In-Vitro Diagnostics (IVD) Market
13.1 Hospitals
13.2 Laboratories
13.3 Home - Care
13.4 Others
14. Europe – In Vitro Diagnostics (IVD) Market
14.1 Germany
14.2 France
14.3 Italy
14.4 Spain
14.5 Netherlands
14.6 Greece
14.7 Portugal
14.8 Belgium
14.9 Sweden
14.10 Austria
14.11 Denmark
14.12 Finland
14.13 Ireland
14.14 Luxembourg
14.15 Poland
14.16 Romania
14.17 Czechia
14.18 Hungary
14.19 Bulgaria
14.20 Slovakia
14.21 Croatia
14.22 Lithuania
14.23 Latvia
14.24 Slovenia
14.25 Estonia
14.26 Cyprus
14.27 Malta
14.28 Switzerland
14.29 Norway
14.30 Iceland
14.31 United Kingdom
14.32 Turkey
15. Company Analysis
15.1 Roche Diagnostics
15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue
15.2 Abbott Diagnostics
15.2.1 Overview
15.2.2 Recent Development
15.2.3 Revenue
15.3 Siemens Healthineers
15.3.1 Overview
15.3.2 Recent Development
15.3.3 Revenue
15.4 Danaher Corporation
15.4.1 Overview
15.4.2 Recent Development
15.4.3 Revenue
15.5 Thermo Fisher Scientific
15.5.1 Overview
15.5.2 Recent Development
15.5.3 Revenue
15.6 Sysmex Corporation
15.6.1 Overview
15.6.2 Recent Development
15.6.3 Revenue
List of Figures:
Figure-01: Europe – In-Vitro Diagnostics (IVD) Market (Billion US$), 2018 – 2022
Figure-02: Europe – Forecast for In-Vitro Diagnostics (IVD) Market (Billion US$), 2023 – 2028
Figure-03: Product – Services Market (Million US$), 2018 – 2022
Figure-04: Product – Forecast for Services Market (Million US$), 2023 – 2028
Figure-05: Product – Instruments Market (Million US$), 2018 – 2022
Figure-06: Product – Forecast for Instruments Market (Million US$), 2023 – 2028
Figure-07: Product – Reagents Market (Million US$), 2018 – 2022
Figure-08: Product – Forecast for Reagents Market (Million US$), 2023 – 2028
Figure-09: Test Types – ELISA & CLIA Market (Million US$), 2018 – 2022
Figure-10: Test Types – Forecast for ELISA & CLIA Market (Million US$), 2023 – 2028
Figure-11: Test Types – PCR Market (Million US$), 2018 – 2022
Figure-12: Test Types – Forecast for PCR Market (Million US$), 2023 – 2028
Figure-13: Test Types – Rapid Test Market (Million US$), 2018 – 2022
Figure-14: Test Types – Forecast for Rapid Test Market (Million US$), 2023 – 2028
Figure-15: Test Types – Fluorescence Immunoassays (FIA) Market (Million US$), 2018 – 2022
Figure-16: Test Types – Forecast for Fluorescence Immunoassays (FIA) Market (Million US$), 2023 – 2028
Figure-17: Test Types – In Situ Hybridization Market (Million US$), 2018 – 2022
Figure-18: Test Types – Forecast for In Situ Hybridization Market (Million US$), 2023 – 2028
Figure-19: Test Types – Transcription Mediated Amplification Market (Million US$), 2018 – 2022
Figure-20: Test Types – Forecast for Transcription Mediated Amplification Market (Million US$), 2023 – 2028
Figure-21: Test Types – Sequencing Market (Million US$), 2018 – 2022
Figure-22: Test Types – Forecast for Sequencing Market (Million US$), 2023 – 2028
Figure-23: Test Types – Colorimetric Immunoassay Market (Million US$), 2018 – 2022
Figure-24: Test Types – Forecast for Colorimetric Immunoassay Market (Million US$), 2023 – 2028
Figure-25: Test Types – Radioimmunoassay (RIA) Market (Million US$), 2018 – 2022
Figure-26: Test Types – Forecast for Radioimmunoassay (RIA) Market (Million US$), 2023 – 2028
Figure-27: Test Types – Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2018 – 2022
Figure-28: Test Types – Forecast for Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2023 – 2028
Figure-29: Test Types – Others Market (Million US$), 2018 – 2022
Figure-30: Test Types – Forecast for Others Market (Million US$), 2023 – 2028
Figure-31: Application – Infectious Disease Market (Million US$), 2018 – 2022
Figure-32: Application – Forecast for Infectious Disease Market (Million US$), 2023 – 2028
Figure-33: Application – Diabetes Market (Million US$), 2018 – 2022
Figure-34: Application – Forecast for Diabetes Market (Million US$), 2023 – 2028
Figure-35: Application – Cardiology Market (Million US$), 2018 – 2022
Figure-36: Application – Forecast for Cardiology Market (Million US$), 2023 – 2028
Figure-37: Application – Oncology Market (Million US$), 2018 – 2022
Figure-38: Application – Forecast for Oncology Market (Million US$), 2023 – 2028
Figure-39: Application – Nephrology Market (Million US$), 2018 – 2022
Figure-40: Application – Forecast for Nephrology Market (Million US$), 2023 – 2028
Figure-41: Application – Autoimmune Diseases Market (Million US$), 2018 – 2022
Figure-42: Application – Forecast for Autoimmune Diseases Market (Million US$), 2023 – 2028
Figure-43: Application – Drug Testing Market (Million US$), 2018 – 2022
Figure-44: Application – Forecast for Drug Testing Market (Million US$), 2023 – 2028
Figure-45: Application – Other Applications Market (Million US$), 2018 – 2022
Figure-46: Application – Forecast for Other Applications Market (Million US$), 2023 – 2028
Figure-47: Technology – Immunoassay Market (Million US$), 2018 – 2022
Figure-48: Technology – Forecast for Immunoassay Market (Million US$), 2023 – 2028
Figure-49: Technology – Clinical Chemistry Market (Million US$), 2018 – 2022
Figure-50: Technology – Forecast for Clinical Chemistry Market (Million US$), 2023 – 2028
Figure-51: Technology – Molecular Diagnostics/Genetics Market (Million US$), 2018 – 2022
Figure-52: Technology – Forecast for Molecular Diagnostics/Genetics Market (Million US$), 2023 – 2028
Figure-53: Technology – Hematology Market (Million US$), 2018 – 2022
Figure-54: Technology – Forecast for Hematology Market (Million US$), 2023 – 2028
Figure-55: Technology – Microbiology Market (Million US$), 2018 – 2022
Figure-56: Technology – Forecast for Microbiology Market (Million US$), 2023 – 2028
Figure-57: Technology – Coagulation Market (Million US$), 2018 – 2022
Figure-58: Technology – Forecast for Coagulation Market (Million US$), 2023 – 2028
Figure-59: Technology – Others Market (Million US$), 2018 – 2022
Figure-60: Technology – Forecast for Others Market (Million US$), 2023 – 2028
Figure-61: End User – Hospitals Market (Million US$), 2018 – 2022
Figure-62: End User – Forecast for Hospitals Market (Million US$), 2023 – 2028
Figure-63: End User – Laboratories Market (Million US$), 2018 – 2022
Figure-64: End User – Forecast for Laboratories Market (Million US$), 2023 – 2028
Figure-65: End User – Home - Care Market (Million US$), 2018 – 2022
Figure-66: End User – Forecast for Home - Care Market (Million US$), 2023 – 2028
Figure-67: End User – Others Market (Million US$), 2018 – 2022
Figure-68: End User – Forecast for Others Market (Million US$), 2023 – 2028
Figure-69: Germany – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-70: Germany – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-71: France – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-72: France – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-73: Italy – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-74: Italy – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-75: Spain – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-76: Spain – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-77: Netherlands – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-78: Netherlands – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-79: Greece – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-80: Greece – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-81: Portugal – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-82: Portugal – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-83: Belgium – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-84: Belgium – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-85: Sweden – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-86: Sweden – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-87: Austria – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-88: Austria – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-89: Denmark – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-90: Denmark – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-91: Finland – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-92: Finland – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-93: Ireland – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-94: Ireland – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-95: Luxembourg – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-96: Luxembourg – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-97: Poland – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-98: Poland – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-99: Romania – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-100: Romania – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-101: Czechia – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-102: Czechia – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-103: Hungary – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-104: Hungary – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-105: Bulgaria – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-106: Bulgaria – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-107: Slovakia – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-108: Slovakia – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-109: Croatia – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-110: Croatia – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-111: Lithuania – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-112: Lithuania – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-113: Latvia – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-114: Latvia – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-115: Slovenia – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-116: Slovenia – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-117: Estonia – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-118: Estonia – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-119: Cyprus – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-120: Cyprus – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-121: Malta – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-122: Malta – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-123: Switzerland – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-124: Switzerland – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-125: Norway – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-126: Norway – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-127: Iceland – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-128: Iceland – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-129: United Kingdom – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-130: United Kingdom – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-131: Turkey – In-Vitro Diagnostics (IVD) Market (Million US$), 2018 – 2022
Figure-132: Turkey – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2023 – 2028
Figure-133: Roche Diagnostics – Global Revenue (Billion US$), 2018 – 2022
Figure-134: Roche Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-135: Abbott Diagnostics – Global Revenue (Billion US$), 2018 – 2022
Figure-136: Abbott Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-137: Siemens Healthineers – Global Revenue (Billion US$), 2018 – 2022
Figure-138: Siemens Healthineers – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-139: Danaher Corporation – Global Revenue (Billion US$), 2018 – 2022
Figure-140: Danaher Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-141: Thermo Fisher Scientific – Global Revenue (Billion US$), 2018 – 2022
Figure-142: Thermo Fisher Scientific – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-143: Sysmex Corporation – Global Revenue (Billion US$), 2018 – 2022
Figure-144: Sysmex Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
List of Tables:
Table-01: Europe – In-Vitro Diagnostics (IVD) Market Share by Products (Percent), 2018 – 2022
Table-02: Europe – Forecast for In-Vitro Diagnostics (IVD) Market Share by Products (Percent), 2023 – 2028
Table-03: Europe – In-Vitro Diagnostics (IVD) Market Share by Test Types (Percent), 2018 – 2022
Table-04: Europe – Forecast for In-Vitro Diagnostics (IVD) Market Share by Test Types (Percent), 2023 – 2028
Table-05: Europe – In-Vitro Diagnostics (IVD) Market Share by Application (Percent), 2018 – 2022
Table-06: Europe – Forecast for In-Vitro Diagnostics (IVD) Market Share by Application (Percent), 2023 – 2028
Table-07: Europe – In-Vitro Diagnostics (IVD) Market Share by Technology (Percent), 2018 – 2022
Table-08: Europe – Forecast for In-Vitro Diagnostics (IVD) Market Share by Technology (Percent), 2023 – 2028
Table-09: Europe – In-Vitro Diagnostics (IVD) Market Share by End User (Percent), 2018 – 2022
Table-10: Europe – Forecast for In-Vitro Diagnostics (IVD) Market Share by End User (Percent), 2023 – 2028
Table-11: Europe – In-Vitro Diagnostics (IVD) Market Share by Countries (Percent), 2018 – 2022
Table-12: Europe – Forecast for In-Vitro Diagnostics (IVD) Market Share by Countries (Percent), 2023 – 2028
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com